DAVID KINGSTON: Open Payments
NPI 1568867638 · ANCHORAGE, AK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,982 in 137 payments from 21 companies in 2025. Trend: 2023 $6,511 · 2024 $2,546 · 2025 $3,982
Food & beverage: $3,181Travel & lodging: $746Education: $34Consulting: $21
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 34 | $1,109 |
| INTUITIVE SURGICAL, INC. | 5 | $746 |
| GENZYME CORPORATION | 19 | $532 |
| GlaxoSmithKline, LLC. | 25 | $394 |
| BioCryst US Sales Co., LLC | 8 | $204 |
| CSL Behring | 9 | $166 |
| Amgen Inc. | 9 | $146 |
| Verona Pharma, Inc. | 4 | $117 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $107 |
| Regeneron Healthcare Solutions, Inc. | 3 | $91 |
Products named: Da Vinci Surgical System, DUPIXENT, FASENRA, TEZSPIRE, NUCALA, ORLADEYO, AIRSUPRA, Ohtuvayre.
Industry payments across AK — which companies pay providers there.
